BBIO News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2019-11-19 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2019-10-11 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.02. |
| 2019-09-12 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2019-07-03 | Current report | SEC filing | BridgeBio Pharma, Inc. filed Form 8-K | BridgeBio Pharma, Inc. filed Form 8-K covering items 5.03,8.01,9.01. |